APAC Aesthetic Medicine Market revenue to cross $7.5 Bn by 2027

Published Date: 2021-05-21

Request a sample

APAC Aesthetic Medicine Market size is set to reach USD 7.5 billon by 2027, according to a latest forecast report by Graphical Research.

Increasing inclination towards enhancing facial and body aesthetics coupled with growing adoption of minimally invasive surgeries will propel the market growth. Rising accessibility to advanced cosmetic procedures that are effective, time-saving, and minimally invasive is boosting the market revenue.

Advancements in surgical as well as non-surgical aesthetic procedures will act as primary driver for APAC aesthetic medicine market growth. Growing demand for aesthetic procedures coupled with increasing investment in R&D will positively impact the industry growth. However, high cost of procedures and dearth of skilled workforce may negatively impact the market demand.

The non-surgical segment held over USD 2 billion revenue in 2020 owing to rising demand for non-invasive procedures and technological advancements including non-invasive laser based vaginal rejuvenation and fat reduction procedures. Growing prevalence of obesity, congenital face, and tooth deformities, as well as prevalence of dermatological conditions will augment the demand for minimally invasive and non-invasive aesthetic procedures in future.

The energy-based segment in the APAC aesthetic medicine market is projected to expand at over 11.3% CAGR between 2021 and 2027. Technologies such as radiofrequency and cryolipolysis are being widely used for several applications including skin rejuvenation and fat reduction, with minimal invasion and blood loss. Rising awareness among population regarding laser-based, radiofrequency-based, light-based and ultrasound devices will thereby broaden the demand for the segment. Furthermore, quick recovery, better outcomes, minimal pain, and less discomfort while procedure will foster the market size.

Browse detailed statistical insights from the report, “Asia Pacific Aesthetic Medicine Market Size By End-use (Hospitals, Ambulatory Surgical Centres, Beauty Centres & Medical Spas, Dermatology Clinics, Home Settings), By Type (Non-surgical, Surgical), By Product (Energy-based {Laser-based Aesthetic Device, Radiofrequency (RF)-based Aesthetic Device, Light-based Aesthetic Device, Ultrasound Aesthetic Device}, Non Energy-based {Botulinum Toxin, Dermal Fillers, Implants [Facial Implants, Breast Implants]}), By Gender (Male {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}, Female {18 Years and Below, 19-34 Years, 35-50 Years, 51-64 Years, 65 Years and Above}), Research Report, Country Outlook (China, Japan, India, Australia, South Korea, Malaysia, Thailand, Singapore, Taiwan, Philippines), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 - 2027” along with the table of contents (ToC) @

https://www.graphicalresearch.com/industry-insights/1795/asia-pacific-aesthetic-medicine-market

The male segment is predicted to register a growth of over 11% from 2021 to 2027 due to technological advancement in male aesthetic procedures such as implants, gynecomastia, and body sculpting procedures. Growing inclination of male population towards non-invasive/minimally invasive procedures and increasing demand for facial aesthetics among the male population will boost the industry growth. Additionally, growing acceptance and awareness about pectoral implants will influence procedure demand among men in the future.

The ambulatory surgical centers (ASC) segment is anticipated to witness over 10.6% CAGR during forecast period on account of increasing preference of people towards single-day procedure that offers minimally invasive procedures. Aesthetic procedures performed at ASC provide various benefits to patients including shorter stay period, cost-effectiveness and reduced risk of hospital acquired infections. Moreover, increasing admission in ASCs for minimally invasive aesthetic procedures will accelerate the market expansion.

The Japan aesthetic medicine market accounted more than USD 500 million in 2020. Growing focus of women augmentation of aesthetic appearance will increase the demand for aesthetic products. Additionally, urge among the geriatric population base to reduce signs of ageing such as deep wrinkles, deflated cheeks, sagging neck, and formation of furrows will increase adoption of various surgical and non-surgical facial aesthetic procedures, thereby driving the market revenue share.

APAC aesthetic medicine market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:

Asia Pacific Market, By Type

  • Non-surgical
  • Surgical

Asia Pacific Market, By Product

  • Energy-based 
    • Laser-based aesthetic device
    • Radiofrequency (RF)-based aesthetic device
    • Light-based aesthetic device
    • Ultrasound aesthetic device
    • Others
  • Non-energy-based 
    • Botulinum toxin
    • Dermal fillers
    • Implants
      • Facial implants
      • Breast implants
      • Others 
    • Others

Asia Pacific Market, By Gender

  • Male 
    • 18 years & below
    • 19-34 years
    • 35-50 years
    • 51-64 years
    • 65 years & above
  • Female 
    • 18 years & below
    • 19-34 years
    • 35-50 years
    • 51-64 years
    • 65 years & above

Asia Pacific Market, By End-use

  • Hospitals
  • Ambulatory surgical centers
  • Beauty centers and medical spas
  • Dermatology clinics
  • Home settings

The above information has been provided for the following countries:

  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Thailand
    • Taiwan
    • Singapore
    • Malaysia
    • Philippines